MYIA
TEVA icon

Mount Yale Investment Advisors’s Teva Pharmaceutical Industries Limited TEVA Stock Holding History

Mount Yale Investment Advisors’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.48M Sell
43,802
-399
-0.9% -$13.3K 0.03% 486
2026
Q1 		$1.33M Buy
+44,201
New +$1.42M 0.03% 457
2018
Q4 		– Sell
-11,594
Closed -$275K – 727
2018
Q3 		$275K Buy
11,594
+11,537
+20,240% +$268K 0.05% 269
2018
Q2 		$1K Buy
+57
New +$1.16K ﹤0.01% 938

Other funds holding TEVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

Mount Yale Investment Advisors's TEVA Position: Q2 2026 in Review

Mount Yale Investment Advisors reduced its Teva Pharmaceutical Industries Limited (TEVA) stake by 0.9% in Q2 2026, selling an estimated $13.3K and leaving 43,802 shares worth $1.48M. The position accounts for 0.03% of the portfolio, ranked #486.

Mount Yale Investment Advisors first reported a position in TEVA in Q2 2018 and has held it in 4 quarters since. 676 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

  • Mount Yale Investment Advisors held 43,802 shares of Teva Pharmaceutical Industries Limited worth $1.48M as of Q2 2026.
  • Mount Yale Investment Advisors sold 399 Teva Pharmaceutical Industries Limited shares in Q2 2026, an estimated $13.3K.
  • Teva Pharmaceutical Industries Limited made up 0.03% of Mount Yale Investment Advisors's portfolio in Q2 2026, its #486 holding.
  • Mount Yale Investment Advisors first reported a position in Teva Pharmaceutical Industries Limited in Q2 2018 and has held it in 4 quarters since.
  • 676 funds tracked by Wall St. Rank held Teva Pharmaceutical Industries Limited as of Q2 2026.

Based on Mount Yale Investment Advisors's 13F filing for Q2 2026, filed 12 Aug 2026.